TP53 and lung carcinoma: Godar et al. [90] showed that p53 inhibited CD44 expression by binding to a noncanonical p53 binding sequence in the CD44 promoter, and the p53 loss resulted in elevated CD44 levels which increased resistance to apoptosis in lung carcinoma cells.